Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, Anaspec

Premium
Applied Biosystems and its joint venture partner, MDS Analystical Technologies, this week said they plan to commercialize the FlashQuant mass spectrometry platform for drug compound screening. MDS Analytical Technologies was formed when MDS acquired Molecular Devices in March then combined it with MDS Sciex.
 
FlashQuant is expected to be the first commercially available system combining triple-quadrupole MS with MALDI technology, the companies said in a statement. In tests with the platform, it delivered a 25-fold increase in speed for small-molecule quantitation, compared to the fastest liquid chromatography-coupled triple-quadrupole mass specs currently on the market, the companies said.
 

 
Anaspec last week launched 69 new antibodies. They include Anti-Wilm's Tumor Protein, Melanoma, and Anti-Renal Cell Carcinoma.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.